Parkinson's disease (PD) is a progressive neurodegenerative disorder that significantly impacts motor function. For patients and healthcare providers, finding effective treatments is paramount. Among the critical pharmaceutical interventions, Rasagiline Mesylate has emerged as a highly effective agent. As a leading manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing high-quality Rasagiline Mesylate to support the development of advanced therapies for this condition.

Rasagiline Mesylate functions as a second-generation, irreversible inhibitor of monoamine oxidase type B (MAO-B). This enzyme is responsible for breaking down dopamine in the brain. By inhibiting MAO-B, Rasagiline Mesylate helps to increase the levels of dopamine, a neurotransmitter crucial for regulating movement. This increase in dopamine can significantly alleviate the motor symptoms associated with Parkinson's disease, such as tremors, rigidity, and bradykinesia (slowness of movement). For those seeking to buy Rasagiline Mesylate online or from a trusted Rasagiline supplier in China, understanding its mechanism is key.

One of the significant advantages of Rasagiline Mesylate over earlier treatments is its lack of amphetamine-like metabolites. Unlike some older MAO inhibitors, Rasagiline does not break down into substances that can cause sympathomimetic side effects. This contributes to a more favorable safety profile for patients. The R-enantiomer of rasagiline is particularly potent, being approximately four times more effective than the S-enantiomer. This necessitates precise synthesis and quality control during manufacturing, a standard NINGBO INNO PHARMCHEM CO.,LTD. upholds.

The recommended dosage for Rasagiline Mesylate is typically 1 mg per day, which can be taken with or without food. It is often used as an adjunct therapy alongside levodopa, helping to manage motor fluctuations that can occur in more advanced stages of Parkinson's disease. By increasing dopamine availability, Rasagiline Mesylate helps patients experience more consistent control over their movements, thereby improving their 'on' time and reducing debilitating 'off' periods. This makes it a sought-after pharmaceutical intermediate for companies looking to purchase (R)-N-2-Propynyl-1-indanamine.

For research scientists and product formulators, sourcing high-purity pharmaceutical intermediates is crucial. NINGBO INNO PHARMCHEM CO.,LTD. serves as a reliable Rasagiline 136236-51-6 manufacturer, ensuring that the product meets stringent quality standards. We understand the importance of a stable supply chain for your manufacturing processes. If you are looking for competitive Rasagiline price for Parkinson's disease treatments, we invite you to contact us for a detailed quote and sample.

In conclusion, Rasagiline Mesylate is a vital pharmaceutical intermediate for modern Parkinson's disease treatment. Its efficacy in managing symptoms, coupled with a favorable safety profile, makes it an indispensable component for drug developers. Partner with NINGBO INNO PHARMCHEM CO.,LTD. for your Rasagiline Mesylate needs and ensure the quality and reliability essential for patient care.